FDA.reportPublic FDA data

methotrexate 25 MG/ML Injectable Solution

RxCUI
1946772
RxNorm name
methotrexate 25 MG/ML Injectable Solution
Display name
methotrexate 25 MG/ML Injectable Solution
Full name
methotrexate 25 MG/ML Injectable Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
METHOTREXATEMETHOTREXATEAlembic Pharmaceuticals Inc.a63364d5-4dfa-49d7-8a5e-c8959ae1d37a2026-04-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1946772
METHOTREXATEMETHOTREXATEAlembic Pharmaceuticals Limitede98b2abd-8068-482e-9ce3-1ab262f0838e2026-04-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1946772
MethotrexateMETHOTREXATEHospira, Inc.0e30eaef-5a09-4104-8a11-c32933eadeab2025-08-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1946772
MethotrexateMETHOTREXATEHospira, Inc.bd287e89-32f9-4396-95fa-4b562869f4762025-06-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1946772
MethotrexateMETHOTREXATEHospira, Inc.0d63ba29-b692-41b4-87e8-351265c8273f2025-06-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1946772
MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCb585f621-f6c9-4735-ab61-bd1b401f3df02021-03-24Boxed warning, Adverse reactionsExact identifier
rxcui: 1946772

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0d63ba29-b692-41b4-87e8-351265c8273fmethotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]319These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 195320250610
0e30eaef-5a09-4104-8a11-c32933eadeabmethotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]317These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 195320250822
bd287e89-32f9-4396-95fa-4b562869f476methotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]36These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 195320250630
b585f621-f6c9-4735-ab61-bd1b401f3df0methotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]36Methotrexate Injection, USP20210324
a63364d5-4dfa-49d7-8a5e-c8959ae1d37amethotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]34These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 195320260416
e98b2abd-8068-482e-9ce3-1ab262f0838emethotrexate 25 MG/mL Injectable Solution [PSN] · methotrexate 25 MG/ML Injectable Solution [SCD] · methotrexate (as methotrexate sodium) 25 MG/ML Injectable Solution [SY]31These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or intrathecal use Initial U.S. Approval: 195320260416